Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating whether curcumin can prevent progression of low-risk prostate cancer in men under active surveillance is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING